Mesirow Financial Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$742K Buy
9,482
+360
+4% +$24.5K 0.01% 309
2026
Q1
$590K Sell
9,122
-360
-4% -$25.4K 0.01% 334
2025
Q4
$638K Sell
9,482
-84
-0.9% -$5.65K 0.01% 295
2025
Q3
$702K Hold
9,566
0.01% 317
2025
Q2
$498K Sell
9,566
-880
-8% -$50.1K 0.01% 366
2025
Q1
$667K Sell
10,446
-9,048
-46% -$526K 0.01% 311
2024
Q4
$932K Buy
19,494
+10,994
+129% +$564K 0.02% 272
2024
Q3
$487K Hold
8,500
0.01% 366
2024
Q2
$445K Hold
8,500
0.01% 351
2024
Q1
$346K Buy
8,500
+500
+6% +$18.7K 0.01% 411
2023
Q4
$296K Buy
+8,000
New +$301K 0.01% 433

Other funds holding HALO

Mesirow Financial Investment Management's HALO Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Halozyme (HALO) stake by 3.9% in Q2 2026, buying an estimated $24.5K and bringing the position to 9,482 shares worth $742K. The position accounts for 0.01% of the portfolio, ranked #309.

Mesirow Financial Investment Management first reported a position in HALO in Q4 2023 and has held it in 11 quarters since. The position peaked at $932K in Q4 2024. 236 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mesirow Financial Investment Management held 9,482 shares of Halozyme worth $742K as of Q2 2026.
  • Mesirow Financial Investment Management bought 360 Halozyme shares in Q2 2026, an estimated $24.5K.
  • Halozyme made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #309 holding.
  • Mesirow Financial Investment Management first reported a position in Halozyme in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Halozyme position peaked at $932K in Q4 2024.
  • 236 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.